British Columbia is the first province in Canada to be paying for the COVID-19 medication Paxlovid.
The federal government has told all provinces it will no longer be paying for the drug used to treat COVID-19. Other provinces are moving the drug to the pharmacare program.
Paxlovid is an anti-viral medication approved by Health Canada in January 2022 for the treatment of mild to moderate COVID-19 in adults at high risk for progression to severe COVID-19 outcomes.
The medication is recommended for people at higher risk of serious illness and hospitalization and treatment must begin within five days of the start of symptoms to be effective.
In addition, a COVID-19 booster remains available in B.C. for those most at risk of severe illness or complications and for those who have not yet received an updated vaccine dose.
However, anyone who feels they would benefit from an additional dose of the XBB.1.5 COVID-19 vaccine can contact the call centre at 1-833-838-2323 to book an appointment or walk into a pharmacy where the vaccine is available, the government said in a release.
- Physical inactivity a ‘silent threat’ as countries, including Canada, off track
- Bird flu vaccinations for humans to begin in Finland, a global first
- Quadriplegic man’s MAID death from bedsore results in public inquiry being ordered
- U.S. doctors perform kidney transplant on awake patient in milestone
Comments